Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bozhen Zhang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2024
A silicon diode-based optoelectronic interface for bidirectional neural modulationXin Fu, Zhengwei Hu, Wenjun Li, et al.
Science China. Life Sciences|March 11, 2016
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cellsFengtao You, Licui Jiang, Bozhen Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/LymphomaMingzhi Zhang, Dan Chen, Xiaorui Fu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2024
A silicon diode-based optoelectronic interface for bidirectional neural modulationXin Fu, Zhengwei Hu, Wenjun Li, et al.
Science China. Life Sciences|March 11, 2016
Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cellsFengtao You, Licui Jiang, Bozhen Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/LymphomaMingzhi Zhang, Dan Chen, Xiaorui Fu, et al.
Pageof 2